DT
Douglas Tsao HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Immunovant
IMVT
$2.81B
| $16.12 | $35 |
117%
upside
| Buy | 18 hours ago |
|
2
Rezolute
RZLT
$642M
| $7.38 | $14 |
90%
upside
| Buy | yesterday |
|
3
Evotec
EVO
$1.2B
| $3.37 | $7 |
108%
upside
| Buy | 21 days ago |
|
4
Biohaven
BHVN
$1.7B
| $16.07 | $30 |
87%
upside
| Buy | 23 days ago |
|
|
RAPP
5
Rapport Therapeutics
RAPP
$560M
| $15.35 | $31 |
102%
upside
| Buy | 29 days ago |
|
6
Evolus
EOLS
$486M
| $7.51 | $20 |
166%
upside
| Buy | 29 days ago |
|
7
Praxis Precision Medicines
PRAX
$970M
| $46.09 | $115 |
150%
upside
| Buy | 1 month ago |
|
8
argenx
ARGX
$44.9B
| $733.66 | $774 |
6%
upside
| Buy | 1 month ago |
|
9
Alkermes
ALKS
$4.77B
| $28.92 | $46 |
59%
upside
| Neutral | 1 month ago |
|
10
Disc Medicine
IRON
$2.09B
| $60.19 | $118 |
96%
upside
| Buy | 2 months ago |
|
11
Crinetics Pharmaceuticals
CRNX
$3.23B
| $34.25 | $81 |
137%
upside
| Buy | 2 months ago |
|
12
Roivant Sciences
ROIV
$8.58B
| $12.57 | $18 |
43%
upside
| Buy | 2 months ago |
|
13
Protagonist Therapeutics
PTGX
$3.71B
| $59.60 | $80 |
34%
upside
| Buy | 3 months ago |
|
14
Xenon Pharmaceuticals
XENE
$2.98B
| $38.64 | $53 |
37%
upside
| Buy | 3 months ago |
|
15
Viridian Therapeutics
VRDN
$1.52B
| $18.64 | $34 |
82%
upside
| Buy | 4 months ago |
|
16
Arcutis Biotherapeutics
ARQT
$1.94B
| $16.21 | $19 |
17%
upside
| Buy | 5 months ago |
|
17
scPharmaceuticals
SCPH
$300M
| $5.58 | $18 |
223%
upside
| Buy | 5 months ago |
|
18
Neumora Therapeutics
NMRA
$264M
| $1.63 | $18 |
1,004%
upside
| Buy | 6 months ago |
|
19
Apellis Pharmaceuticals
APLS
$3.62B
| $28.65 | $57 |
99%
upside
| Buy | 6 months ago |
|
20
Theravance Biopharma
TBPH
$708M
| $14.05 | $15 |
7%
upside
| Buy | 6 months ago |
|
21
Icon
ICLR
$13.7B
| $176.36 | $182 |
3%
upside
| Equal-Weight | 5 years ago |
|